This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Aug 19:341:c4102.

doi: 10.1136/bmj.c4102.

How long should treatments be continued?

Jonathan C Craig, Angela C Webster, Clement Loy

PMID: 20724403
DOI: 10.1136/bmj.c4102

Editorial

How long should treatments be continued?

Jonathan C Craig et al. BMJ. 2010.

. 2010 Aug 19:341:c4102.

doi: 10.1136/bmj.c4102.

Authors

Jonathan C Craig, Angela C Webster, Clement Loy

PMID: 20724403
DOI: 10.1136/bmj.c4102

No abstract available

PubMed Disclaimer

Comment in

Length of treatment. Three questions for prescribers.
Aronson JK, Ferner RE. Aronson JK, et al. BMJ. 2010 Sep 15;341:c5013. doi: 10.1136/bmj.c5013. BMJ. 2010. PMID: 20843922 No abstract available.

Comment on

Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.
Chen EY, Hui CL, Lam MM, Chiu CP, Law CW, Chung DW, Tso S, Pang EP, Chan KT, Wong YC, Mo FY, Chan KP, Yao TJ, Hung SF, Honer WG. Chen EY, et al. BMJ. 2010 Aug 19;341:c4024. doi: 10.1136/bmj.c4024. BMJ. 2010. PMID: 20724402 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information